BioBridge

BioBridge Ltd was founded in 1989 by Meredith Lloyd-Evans and has been at the forefront of biotechnology and life science advances since then.

BioBridge is one of the longest-established small independent innovation consultancies in Cambridge, with expertise in regulatory strategy and practical assistance, business strategy, technology analysis and market dynamics of human health products, biomaterials, advanced cell systems, biotechnology in health, veterinary medicines, animal feed additives and biotechnology in agrifood. Our experience in the entire innovation chain means that regulatory projects will always be undertaken in the broader context of innovation development and market strategy, and our input can be expected in these areas too, which produces an added-value service. In addition, value is added by BioBridge’s wider network of associates active in boardroom strategy, food, agriculture, the chemical industry, healthcare and in PR, technology transfer and other sectoral and functional areas.

The impact of regulation may seem to be an end-of-development issue, but it needs to be taken into account at the earliest stages of business activity. This is especially important for companies and organisations working in innovative areas. We can provide support at all stages of product development and for all parts of the regulatory process, either in-house or with a range of trusted and expert associates, including manufacturing, process validation, clinical studies and pharmacovigilance.



BioBridge can also underpin strategy through its extensive affiliations with national and international bodies and government agencies such as the US Biotechnology Industry Organization, the UK BioIndustry Association, The Organisation for Professionals in Regulatory Affairs, the FDA, MHRA, EMEA and the European Commission. Associates are also recognised experts and lobbyists at European Commission level.

Meredith Lloyd-Evans graduated from the University of Cambridge UK as a veterinary surgeon and spent 4 years in general practice in Canada and UK before joining SmithKline Animal Health Products as Veterinary Adviser in 1977. He became Technical Director for the UK company, responsible for final-stage and field product development, regulatory affairs, Government liaison, training, manufacturing compliance, product pharmacovigilance investigation, in-licensing evaluations and departmental management, and Pharmaceutical Product Development Co-ordinator for SKAHP Europe, before leaving to join British Technology Group in 1985. Here, he looked after and expanded a portfolio of inventions, projects and licences in biotechnology, drug delivery and animal health. Then, at PA Technology, he briefly worked on a number of product and company diversification projects in food, agricultural resources, the chemical industry and animal health, before setting up BioBridge in 1989. He is a Fellow of TOPRA (the Organisation for Professional in Regulatory Affairs) and was Board Member and Secretary for a number of years. As a member of the Association of Veterinary Consultants, an independent international body consulted by the EMEA, European Commission and European Food Safety Authority, and its General Secretary 2005-2006, he has been involved in high-level discussions of draft directives, guidelines, position papers and other regulatory items over the past 15 years.

Recent publications include The Regulation of tissue-engineered products in Materials Today, Elsevier; Reimbursement, ethics and regulations for advanced devices for the Royal Academy of Engineering in the report of the UK Science Mission to Japan on Tissue Engineering; Issues in Chemistry, Manufacture and Control for novel products in RAPS Regulatory Affairs Focus; & Regulatory Issues in Biopharming for ESRA Rapporteur. Meredith will be speaking in October at VetHealth Global 2009, Prince Edward Island Canada, on regulation of innovative animal health and nutrition products in Europe.

Contact::

Peter Barfoot peter.barfoot@bioportfolio.com